Award Categories include Device Design, Innovation and Leadership which recognize achievements in manufacturing, technology, materials and team performance.
Companies spoke about the need for navigation, robotics and AI at NASS 2024.
Outpatient surgery is the vanguard of modern healthcare and the future of surgical and medical innovation, says an ASC investor.
The project will use Naitive’s OsteoSight technology to estimate the prevalence of low bone mineral density in THA and TKA patients.
The move expands Heraeus’ strategic business unit with resorbable biomaterials for use in regenerative orthopedics.
The companies will combine Arthrolense 4Di visual guidance with the LinkSymphoKnee and other knee implant solutions across revision indications.
The companies will join forces with the Clench Compression Staple, a fully disposable fixation device for orthopedic and podiatric surgeons.
J&J MedTech announced it will spin off its orthopedics business into a stand alone company called DePuy Synthes within the next two years.
Within 3Q25, these companies debuted products to help fix our fractures and deformities in shoulders, pelvis and toes throughout our ages.
Founded in 2016, Isto Biologics is a regenerative medtech company developing and manufacturing orthobiologic products to help patients heal faster.
TiRobot is an autonomous cobot that is not fixed to the operating table, allowing for continuous adjustments throughout the procedure according to surgical needs.
The partners will leverage KORU Medical’s FreedomEDGE infusion system as part of ForCast’s platform for the treatment of periprosthetic joint infection.
The addition of these technologies will allow Demetra to expand its portfolio of infection management solutions.
The next-generation, radiation-free optical navigation complements the Highridge portfolio of enabling technologies.
VergenixSTR for the treatment of tendinopathy is now available in Poland.
This collaboration will expand access of Elute’s BonVie+ bone graft substitute to physicians and patients at U.S. VA and DoD medical facilities worldwide.
New systems seek to simplify use of the technology by tapping into equipment in the O.R., offering ASC-friendly sizes and including AI applications.
This collaboration will expand access to MY01’s Continuous Perfusion Sensing Technology Platform for children and adolescents, a population at great risk for acute compartment syndrome.
Login
Register for a free account
As a guest member you get access to more articles and videos every month.
